Alcami Completes Acquisition of Tjoapack

Alcami Corporation has successfully completed the acquisition of Tjoapack, a prominent global contract packaging organization, in a deal that enhances Alcami's contract development and manufacturing organization (CDMO) capabilities across the U.S. and Europe. The financial terms of the transaction remain undisclosed. This strategic move, announced on May 5, 2026, positions Alcami to better serve its pharmaceutical and biotech clients by expanding its operational footprint and packaging capabilities.

The acquisition of Tjoapack significantly bolsters Alcami's scale and supply chain redundancy, crucial factors for pharmaceutical and biotech customers who require reliable and efficient services. With the integration of Tjoapack, the combined organization now employs over 1,400 personnel across the U.S. and The Netherlands, thereby strengthening its workforce and expertise in the sector. The operational footprint of the newly formed entity exceeds 1 million square feet, facilitating the production of over 80 commercial products worldwide. This expansion is expected to enhance service delivery and operational efficiency for both companies' existing and future clients.

Alcami's CEO, Patrick Walsh, will lead the combined organization, emphasizing the importance of strategic leadership during this transition. The merger is anticipated to provide Tjoapack's customers with uninterrupted service while simultaneously granting them access to Alcami's expansive portfolio of capabilities, which includes drug product manufacturing, laboratory services, and pharmaceutical storage. Furthermore, Alcami's existing customers will benefit from increased packaging scale and enhanced market access support, particularly through Qualified Person (QP) release services in Europe.

The pharmaceutical and biotech sectors are experiencing significant growth, driven by increasing demand for innovative therapies and a heightened focus on supply chain resilience. The acquisition of Tjoapack aligns with Alcami's long-term growth strategy to deliver integrated global solutions to its clients. By expanding its capabilities and operational reach, Alcami is well-positioned to capitalize on emerging market opportunities and navigate the evolving landscape of pharmaceutical manufacturing and packaging.

In summary, the acquisition of Tjoapack by Alcami Corporation represents a strategic enhancement of CDMO capabilities in a growing market. As the combined organization integrates its operations, it is expected to unlock new efficiencies and service offerings that will benefit clients across the pharmaceutical and biotech sectors. The deal underscores the ongoing trend of consolidation within the industry as companies seek to strengthen their competitive positions and enhance their service offerings in response to evolving client needs.